Preliminary investigation of the in vitro anti-Helicobacter pylori activity of Triphala
These findings suggest that Triphala exerts inhibitory effects on <i>H. pylori</i> activity through multiple mechanisms, underscoring its potential as a new drug for the prevention and treatment of <i>H. pylori</i> infection.
Authors
- Ling Ou (ORCID: https://orcid.org/0000-0002-4437-6427)
- Bingmei Su (ORCID: https://orcid.org/0000-0001-7785-3798)
- Yuanjing Zou
- Yajie Hao (ORCID: https://orcid.org/0000-0001-7087-7666)
- Hui Li (ORCID: https://orcid.org/0000-0002-4611-7808)
- Junwei Jia
- Liping Zhang (ORCID: https://orcid.org/0000-0002-9754-5829)
- Zhong Feng (ORCID: https://orcid.org/0000-0001-6522-859X)
- Guimin Zhang (ORCID: https://orcid.org/0000-0001-7937-0917)
- Meiyun Chen (ORCID: https://orcid.org/0000-0002-3129-5978)
- Ruixia Wei
- Zhixiang Zhu (ORCID: https://orcid.org/0000-0002-7476-309X)
- Meicun Yao
- Yuqian Lai
- Y. Pang
Institutions
- Sun Yat-sen University (CN)
- Luye Pharma (China) (CN)
- Ocean University of China (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2024-11-19
- DOI
- https://doi.org/10.3389/fphar.2024.1438193
- Citations
- 4
- Primary Topic
- Helicobacter pylori-related gastroenterology studies
- Type
- article
- Field-Weighted Citation Impact
- 2.29
Funders
- Taishan Industry Leading Talents